Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients

Saurin Chokshi, Armin Ghobadi, Mohammed Athar, Sachin Shah, Jonathan Dowell

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Background: Comorbidity is a determinant of treatment selection and survival in various cancers including head and neck cancer (HNC) and is often associated with a higher utilization of non-curative intent treatment. Patients and Methods: In this retrospective study we analyzed 182 consecutively treated HNC patients >65 years old at the Dallas Veterans Affairs Medical Center from January 2000-June 2007. Comorbidity was assessed with the Charlson Comorbidity Index (CCI). Treatment was classified as curative vs. non-curative intent. Results: Median overall survival was 883 days. Patients with a CCI score 0-2 had non-significant higher rate of curative intent treatment than patients with CCI score >2 (83.8% vs. 74.6%, p=0.13). In multivariate analysis, only stage had significant prognostic importance (hazard ratio (HR) 1.66; 95% confidence interval (CI) 1.29-2.14; p<0.0005). In separate multivariate analyses of patients treated with surgery or chemoradiation, CCI was not a significant predictor of survival with HR of 0.88 (95% CI 0.69-1.11; p=0.29) and 1.13 (95% CI 0.83-1.53; p=0.44), respectively. Conclusion: In our elderly HNC population, CCI was not an independent predictor of selection of curative intent treatment or overall survival.

Original languageEnglish (US)
Pages (from-to)5543-5546
Number of pages4
JournalAnticancer Research
Volume34
Issue number10
StatePublished - Oct 1 2014

Fingerprint

Head and Neck Neoplasms
Comorbidity
Survival
Confidence Intervals
Therapeutics
Multivariate Analysis
Veterans
Retrospective Studies
Population

Keywords

  • Charlson comorbidity index
  • Comorbidity
  • Elderly
  • Head and neck cancer
  • Survival.

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients. / Chokshi, Saurin; Ghobadi, Armin; Athar, Mohammed; Shah, Sachin; Dowell, Jonathan.

In: Anticancer Research, Vol. 34, No. 10, 01.10.2014, p. 5543-5546.

Research output: Contribution to journalArticle

Chokshi, Saurin ; Ghobadi, Armin ; Athar, Mohammed ; Shah, Sachin ; Dowell, Jonathan. / Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients. In: Anticancer Research. 2014 ; Vol. 34, No. 10. pp. 5543-5546.
@article{9c5bb8220a034f0693fc5ce6bc9eb999,
title = "Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients",
abstract = "Background: Comorbidity is a determinant of treatment selection and survival in various cancers including head and neck cancer (HNC) and is often associated with a higher utilization of non-curative intent treatment. Patients and Methods: In this retrospective study we analyzed 182 consecutively treated HNC patients >65 years old at the Dallas Veterans Affairs Medical Center from January 2000-June 2007. Comorbidity was assessed with the Charlson Comorbidity Index (CCI). Treatment was classified as curative vs. non-curative intent. Results: Median overall survival was 883 days. Patients with a CCI score 0-2 had non-significant higher rate of curative intent treatment than patients with CCI score >2 (83.8{\%} vs. 74.6{\%}, p=0.13). In multivariate analysis, only stage had significant prognostic importance (hazard ratio (HR) 1.66; 95{\%} confidence interval (CI) 1.29-2.14; p<0.0005). In separate multivariate analyses of patients treated with surgery or chemoradiation, CCI was not a significant predictor of survival with HR of 0.88 (95{\%} CI 0.69-1.11; p=0.29) and 1.13 (95{\%} CI 0.83-1.53; p=0.44), respectively. Conclusion: In our elderly HNC population, CCI was not an independent predictor of selection of curative intent treatment or overall survival.",
keywords = "Charlson comorbidity index, Comorbidity, Elderly, Head and neck cancer, Survival.",
author = "Saurin Chokshi and Armin Ghobadi and Mohammed Athar and Sachin Shah and Jonathan Dowell",
year = "2014",
month = "10",
day = "1",
language = "English (US)",
volume = "34",
pages = "5543--5546",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "10",

}

TY - JOUR

T1 - Impact of comorbidity on initial treatment and overall survival in elderly head and neck cancer patients

AU - Chokshi, Saurin

AU - Ghobadi, Armin

AU - Athar, Mohammed

AU - Shah, Sachin

AU - Dowell, Jonathan

PY - 2014/10/1

Y1 - 2014/10/1

N2 - Background: Comorbidity is a determinant of treatment selection and survival in various cancers including head and neck cancer (HNC) and is often associated with a higher utilization of non-curative intent treatment. Patients and Methods: In this retrospective study we analyzed 182 consecutively treated HNC patients >65 years old at the Dallas Veterans Affairs Medical Center from January 2000-June 2007. Comorbidity was assessed with the Charlson Comorbidity Index (CCI). Treatment was classified as curative vs. non-curative intent. Results: Median overall survival was 883 days. Patients with a CCI score 0-2 had non-significant higher rate of curative intent treatment than patients with CCI score >2 (83.8% vs. 74.6%, p=0.13). In multivariate analysis, only stage had significant prognostic importance (hazard ratio (HR) 1.66; 95% confidence interval (CI) 1.29-2.14; p<0.0005). In separate multivariate analyses of patients treated with surgery or chemoradiation, CCI was not a significant predictor of survival with HR of 0.88 (95% CI 0.69-1.11; p=0.29) and 1.13 (95% CI 0.83-1.53; p=0.44), respectively. Conclusion: In our elderly HNC population, CCI was not an independent predictor of selection of curative intent treatment or overall survival.

AB - Background: Comorbidity is a determinant of treatment selection and survival in various cancers including head and neck cancer (HNC) and is often associated with a higher utilization of non-curative intent treatment. Patients and Methods: In this retrospective study we analyzed 182 consecutively treated HNC patients >65 years old at the Dallas Veterans Affairs Medical Center from January 2000-June 2007. Comorbidity was assessed with the Charlson Comorbidity Index (CCI). Treatment was classified as curative vs. non-curative intent. Results: Median overall survival was 883 days. Patients with a CCI score 0-2 had non-significant higher rate of curative intent treatment than patients with CCI score >2 (83.8% vs. 74.6%, p=0.13). In multivariate analysis, only stage had significant prognostic importance (hazard ratio (HR) 1.66; 95% confidence interval (CI) 1.29-2.14; p<0.0005). In separate multivariate analyses of patients treated with surgery or chemoradiation, CCI was not a significant predictor of survival with HR of 0.88 (95% CI 0.69-1.11; p=0.29) and 1.13 (95% CI 0.83-1.53; p=0.44), respectively. Conclusion: In our elderly HNC population, CCI was not an independent predictor of selection of curative intent treatment or overall survival.

KW - Charlson comorbidity index

KW - Comorbidity

KW - Elderly

KW - Head and neck cancer

KW - Survival.

UR - http://www.scopus.com/inward/record.url?scp=84917710463&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84917710463&partnerID=8YFLogxK

M3 - Article

VL - 34

SP - 5543

EP - 5546

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 10

ER -